NLRP3 and early-onset autosomal dominant Alzheimer disease: There is a good deal of evidence linking inflammasomes, including NLRP3, with the induction of neuroinflammation and promotion of neurodegeneration, encompassing disorders such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis [42].